NYSE - Nasdaq Real Time Price USD
Merck & Co., Inc. (MRK)
79.49
+0.45
+(0.57%)
As of 11:11:11 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 24 | 24 |
| Avg. Estimate | 2.05 | 2.45 | 8.92 | 9.76 |
| Low Estimate | 1.89 | 2.33 | 8.79 | 8.93 |
| High Estimate | 2.3 | 2.53 | 9.05 | 10.33 |
| Year Ago EPS | 2.28 | 1.57 | 7.65 | 8.92 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 13 | 24 | 24 |
| Avg. Estimate | 15.86B | 17.14B | 65.08B | 68.76B |
| Low Estimate | 15.52B | 16.81B | 64.16B | 66.76B |
| High Estimate | 16.23B | 17.44B | 66.43B | 72.33B |
| Year Ago Sales | 16.11B | 16.66B | 64.17B | 65.08B |
| Sales Growth (year/est) | -1.55% | 2.92% | 1.42% | 5.66% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 2.14 | 1.57 | 1.67 | 2.14 |
| EPS Actual | 2.28 | 1.57 | 1.72 | 2.22 |
| Difference | 0.14 | 0 | 0.05 | 0.08 |
| Surprise % | 6.31% | 0.03% | 3.30% | 3.98% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 2.05 | 2.45 | 8.92 | 9.76 |
| 7 Days Ago | 2.11 | 2.45 | 8.94 | 9.81 |
| 30 Days Ago | 2.19 | 2.45 | 8.98 | 9.87 |
| 60 Days Ago | 2.18 | 2.46 | 8.98 | 9.93 |
| 90 Days Ago | 2.25 | 2.37 | 9.26 | 10.24 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 4 | 6 | 6 |
| Up Last 30 Days | 1 | 6 | 4 | 7 |
| Down Last 7 Days | 4 | 1 | 9 | 10 |
| Down Last 30 Days | 10 | 5 | 12 | 11 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MRK | -9.92% | 56.24% | 16.59% | 9.48% |
| S&P 500 | 12.38% | 3.18% | 8.00% | 13.86% |
Upgrades & Downgrades
| Initiated | Cantor Fitzgerald: Neutral | 4/22/2025 |
| Reiterates | Guggenheim: Buy to Buy | 4/17/2025 |
| Downgrade | Deutsche Bank: Buy to Hold | 2/18/2025 |
| Maintains | Guggenheim: Buy to Buy | 2/12/2025 |
| Maintains | B of A Securities: Buy to Buy | 2/5/2025 |
| Maintains | BMO Capital: Market Perform to Market Perform | 2/5/2025 |
Related Tickers
BMY Bristol-Myers Squibb Company
47.71
+0.29%
PFE Pfizer Inc.
22.86
-0.09%
JNJ Johnson & Johnson
156.47
+1.29%
ABBV AbbVie Inc.
187.83
+0.36%
AMGN Amgen Inc.
272.16
+0.64%
OGN Organon & Co.
8.79
-3.78%
NVO Novo Nordisk A/S
67.65
+2.05%
LLY Eli Lilly and Company
775.50
+0.05%
GILD Gilead Sciences, Inc.
98.51
+0.64%
GSK GSK plc
37.00
-1.35%